An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.
about
Plant-based oral vaccines against zoonotic and non-zoonotic diseasesAnalyzing the molecular mechanism of lipoprotein localization in BrucellaRecent advances in Brucella abortus vaccinesImmunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approachProtective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice.Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51Meta-Analysis and Advancement of Brucellosis Vaccinology.Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challengeA history of the development of Brucella vaccines.Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice.U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in MiceConfronting the barriers to develop novel vaccines against brucellosis.Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.Overview of plant-made vaccine antigens against malaria.Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.Serving the new masters - dendritic cells as hosts for stealth intracellular bacteria.Transgenic plants: a 5-year update on oral antipathogen vaccine development.Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitroSurvey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.Convergent evolution of plant and animal embryo defences by hyperstable non-digestible storage proteins.Variability in the response of canine and human dendritic cells stimulated with Brucella canis.Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.Effect of immunization routes and protective efficacy of Brucella antigens delivered via Salmonella vector vaccine.
P2860
Q26738581-B793249A-0706-4AFF-859E-680AB0241DF1Q27003985-80A0D647-6D7C-433E-8C98-0E426A995C65Q34484123-F23BE81C-827E-4728-9EFF-9572AD6FDFA8Q34637943-AD63026E-AA3A-4474-9355-00CDA8B3CB35Q35273029-0B0EDD66-1331-41B0-8ECD-025F1C177CD9Q35661526-2D191CD8-D24A-4061-9D94-9F5CFE74D3CAQ35767656-4E21098E-1341-4B91-BC9C-21776A90CFB8Q36192841-ECF586B9-13F1-40AF-879C-3EA5A41BDB0DQ36396770-65F8AAD1-C90B-4279-AC7F-0182AEE3CE3EQ36932453-0E46DBFE-DB64-4607-A8DA-EF5EDC7023D9Q36938722-48E7A381-CE1C-469A-A32C-F1393D4E12C0Q37336032-8CB5D0E3-0E77-499E-9BF5-A4D0C3FA95B4Q37647549-8119F86C-0D6A-4413-9308-9BB975C11B57Q37932521-0FEB66F5-E718-4A05-B275-2592457618E8Q37965725-E541803E-7BE7-47DD-A985-0C41AE82D16AQ38036581-0F2D84AC-D83B-4616-8979-8D34FCAE26D9Q38110546-B327D1D3-E916-44A3-8D78-6305B1D886D5Q38116535-708C73F2-E418-4FC5-99EE-8A7A345E24EFQ38243438-B09C186E-A8DD-4BF2-9496-B90AF557EA11Q39044190-0EBB60AE-78E2-4194-8EF7-19564F7E9414Q41810950-5DC2479C-E64A-4214-9BDF-0D3EC5EB6C92Q43177186-5A0D3D33-B769-4552-9C17-87964771FB12Q45970531-33D2BC58-9725-428D-8932-23AE51FF4B5AQ46269912-6689DAA7-DB69-4CF7-9E3F-34A7321A1E9BQ47163895-2F50757C-F27D-47AC-85DC-AC8A485F0ABBQ49804738-0992D015-7E19-41AF-9B41-DEEF5B9EAA62
P2860
An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@ast
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@en
type
label
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@ast
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@en
prefLabel
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@ast
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@en
P2093
P2860
P1433
P1476
An oral vaccine based on U-Omp ...... IL-17 immune response in mice.
@en
P2093
Andrés E Ibañez
Astrid Zwerdling
Christine Seither
Clara García Samartino
Fernanda S Oliveira
Guillermo H Giambartolomei
Heribert Warzecha
Lorena M Coria
Paula Barrionuevo
Sergio C Oliveira
P2860
P304
P356
10.1371/JOURNAL.PONE.0016203
P407
P577
2011-01-14T00:00:00Z